GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Debt-to-EBITDA

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Debt-to-EBITDA : 0.00 (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Oxford Cannabinoid Technologies Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2023 was €0.00 Mil. Oxford Cannabinoid Technologies Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2023 was €0.00 Mil. Oxford Cannabinoid Technologies Holdings's annualized EBITDA for the quarter that ended in Oct. 2023 was €-5.50 Mil. Oxford Cannabinoid Technologies Holdings's annualized Debt-to-EBITDA for the quarter that ended in Oct. 2023 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Oxford Cannabinoid Technologies Holdings's Debt-to-EBITDA or its related term are showing as below:

FRA:0CB's Debt-to-EBITDA is not ranked *
in the Biotechnology industry.
Industry Median: 1.355
* Ranked among companies with meaningful Debt-to-EBITDA only.

Oxford Cannabinoid Technologies Holdings Debt-to-EBITDA Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Debt-to-EBITDA Chart

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Debt-to-EBITDA
N/A - -0.05 -0.06 -

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only -0.04 -0.01 - - -

Competitive Comparison of Oxford Cannabinoid Technologies Holdings's Debt-to-EBITDA

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Cannabinoid Technologies Holdings's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's Debt-to-EBITDA falls into.



Oxford Cannabinoid Technologies Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Oxford Cannabinoid Technologies Holdings's Debt-to-EBITDA for the fiscal year that ended in Apr. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -7.945
=0.00

Oxford Cannabinoid Technologies Holdings's annualized Debt-to-EBITDA for the quarter that ended in Oct. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -5.502
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Oct. 2023) EBITDA data.


Oxford Cannabinoid Technologies Holdings  (FRA:0CB) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Oxford Cannabinoid Technologies Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines